These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 30726973)

  • 1. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
    Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
    J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
    Altawalah H; Essa S; Ezzikouri S; Al-Nakib W
    Sci Rep; 2019 Apr; 9(1):6292. PubMed ID: 31000775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
    Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.
    Rashti R; Alavian SM; Moradi Y; Sharafi H; Mohamadi Bolbanabad A; Roshani D; Moradi G
    Arch Virol; 2020 Sep; 165(9):1947-1958. PubMed ID: 32617764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
    Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
    Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with infection of blood-borne virus among people who used methamphetamine.
    Cai Y; Dai Z; Wen S; Bhandari R
    BMC Infect Dis; 2020 Oct; 20(1):742. PubMed ID: 33036558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
    Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
    J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
    Aghaei AM; Gholami J; Sangchooli A; Rostam-Abadi Y; Olamazadeh S; Ardeshir M; Baheshmat S; Shadloo B; Taj M; Saeed K; Rahimi-Movaghar A
    Lancet Glob Health; 2023 Aug; 11(8):e1225-e1237. PubMed ID: 37474230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania.
    Kawambwa RH; Majigo MV; Mohamed AA; Matee MI
    BMC Public Health; 2020 Feb; 20(1):177. PubMed ID: 32019536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain.
    Toro C; Jiménez V; Rodríguez C; Del Romero J; Rodés B; Holguín A; Alvarez P; García-Campello M; Gómez-Hernando C; Guelar A; Sheldon J; de Mendoza C; Simón A; Soriano V
    J Med Virol; 2006 Dec; 78(12):1599-608. PubMed ID: 17063510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.